Media

Xeris Biopharma Announces Gvoke® Kit Is Now Available for the Treatment of Severe Hypoglycemia in Adults and Children With Diabetes Ages 2 And Above

Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals

Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Business Operations

Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates

Spruce Biosciences Appoints Will Charlton, M.D., M.A.S., as Chief Medical Officer

Nordic Nanovector ASA – Final results of the subsequent offering

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology

Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events

Xeris Announces $150M Senior Secured Term Loan Facility With Hayfin Capital

Digital mental health company HelloBetter raises Series A extension led by MassMutual Ventures